| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achievement of Specified Lipid and High-Sensitivity C-Reactive Protein Levels with Statin-Ezetimibe Versus Statin in Male and Female Patients Using Combined Data from 22,913 Patients
|
Robinson, Jennifer
|
|
2010
|
4 |
3 |
p. 200-201
2 p.
|
artikel
|
| 2 |
Acute Reduction of Lipoprotein (a) After Low-Density Lipoprotein Apheresis May Improve Symptoms of Angina∗
|
Bulchandani, Deepti
|
|
2010
|
4 |
3 |
p. 217-218
2 p.
|
artikel
|
| 3 |
Adding Niacin Extended-Release (NER) to Simvastatin Improves Apolipoprotein B (apoB), apoA-I, the apoB:A-I Ratio, and Lipid Goal Attainment in the Highest-Risk Cardiometabolic Patients
|
Doan, Thao T.
|
|
2010
|
4 |
3 |
p. 212-213
2 p.
|
artikel
|
| 4 |
Aging: The New Cholesterol
|
Nash, David T.
|
|
2010
|
4 |
3 |
p. 202-
1 p.
|
artikel
|
| 5 |
A New Method to Evaluate the Hydrophility of Serum Lipoproteins
|
Schrot, Gűnter
|
|
2010
|
4 |
3 |
p. 199-
1 p.
|
artikel
|
| 6 |
A Plant Sterol/Stanol Supplement in Tablet Form Lowers Low-Density Lipoprotein and Non-High-Density Lipoprotein Cholesterol in Men and Women with Primary Hypercholesterolemia
|
Maki, Kevin Carl
|
|
2010
|
4 |
3 |
p. 211-212
2 p.
|
artikel
|
| 7 |
A Readiness Analysis of the NCQA Diabetes Physician Recognition Program Standards Attainment for a Chicagoland Family Practice Group
|
Glosner, Scott E.
|
|
2010
|
4 |
3 |
p. 228-229
2 p.
|
artikel
|
| 8 |
Aspirin Improves Niacin-Associated Flushing and its Impact on Dyslipidemic Patients' Quality of Life
|
Dong, Thao T.
|
|
2010
|
4 |
3 |
p. 214-
1 p.
|
artikel
|
| 9 |
Aspirin Reduces Transient Flushing and Glucose Increases During Therapy with Niacin Extended-Release
|
Padley, Robert J.
|
|
2010
|
4 |
3 |
p. 213-214
2 p.
|
artikel
|
| 10 |
Associations Between Switches to Simvastatin and Low-Density Lipoprotein Goal Attainment Among High-Risk Patients in a US Managed-Care Population
|
Neff, David Robert
|
|
2010
|
4 |
3 |
p. 219-
1 p.
|
artikel
|
| 11 |
Atherogenic High-Density Lipoprotein in Subjects with Hyperalphalipoproteinemia
|
McNeal, Catherine Janise
|
|
2010
|
4 |
3 |
p. 210-
1 p.
|
artikel
|
| 12 |
Attainment of Dual Treatment Levels for High-Sensitivity C-Reactive Protein and Lipids in Older (>65 Years) Patients with Cardiovascular Disease Risk: Ezetimibe/Simvastatin Versus Atorvastatin
|
Zieve, Franklin Joseph
|
|
2010
|
4 |
3 |
p. 222-
1 p.
|
artikel
|
| 13 |
Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
|
Kauffman, Amy B.
|
|
2010
|
4 |
3 |
p. 173-180
8 p.
|
artikel
|
| 14 |
A Variant of the LPA Gene Predicts Cardiovascular Event Reduction by Aspirin Therapy in a Primary Prevention Setting
|
Superko, Robert H.
|
|
2010
|
4 |
3 |
p. 212-
1 p.
|
artikel
|
| 15 |
BGS Graph Predicts Better Than the Framingham Risk Score
|
Feeman Jr., William E.
|
|
2010
|
4 |
3 |
p. 203-
1 p.
|
artikel
|
| 16 |
Blood Sugar Levels are Not Necessary to Predict the Population at Risk for Atherothrombotic Disease
|
Feeman Jr., William E.
|
|
2010
|
4 |
3 |
p. 204-
1 p.
|
artikel
|
| 17 |
Can Hypoglycemia be Used as a Marker of Outcome in Hospitalized Non-Diabetics∗
|
Blosch, Annette Kristina
|
|
2010
|
4 |
3 |
p. 228-
1 p.
|
artikel
|
| 18 |
Change Heart and Vascular Risk with Attitude, Nutrition, Goals, and Exercise (CHANGE)
|
Goldenberg, Edward Mark
|
|
2010
|
4 |
3 |
p. 221-222
2 p.
|
artikel
|
| 19 |
Changes in Prescription Patterns for Ezetimibe/Simvastatin, Ezetimibe and Statin, and Statin Therapies and Expected Effects on LDL-C Reduction
|
Toth, Peter Paul
|
|
2010
|
4 |
3 |
p. 219-220
2 p.
|
artikel
|
| 20 |
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
|
Abela, George S.
|
|
2010
|
4 |
3 |
p. 156-164
9 p.
|
artikel
|
| 21 |
Clinical Pharmacist Services Significantly Increase Low-Density Lipoprotein Cholesterol Goal Attainment in an Outpatient-Based Lipid Clinic
|
Gupta, Eric K.
|
|
2010
|
4 |
3 |
p. 208-
1 p.
|
artikel
|
| 22 |
Colesevelam HCl to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study
|
Misir, Sam
|
|
2010
|
4 |
3 |
p. 220-
1 p.
|
artikel
|
| 23 |
Comparison of Attainment of Diabetes Goals and Knowledge Between Traditional Practice Settings and a Dietitian/Nurse Practitioner-Run Lipid Clinic
|
Lloyd, Kristina M.
|
|
2010
|
4 |
3 |
p. 223-224
2 p.
|
artikel
|
| 24 |
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: The Stop Atherosclerosis in Native Diabetics Study (SANDS)
|
Wilson, Charlton
|
|
2010
|
4 |
3 |
p. 165-172
8 p.
|
artikel
|
| 25 |
Cost Effectiveness of Prescription Strength Omega-3 in Individuals with Severe Hypertriglyceridemia
|
Arondekar, Bhakti
|
|
2010
|
4 |
3 |
p. 230-
1 p.
|
artikel
|
| 26 |
Editorial Board
|
|
|
2010
|
4 |
3 |
p. iii-iv
nvt p.
|
artikel
|
| 27 |
Effect of Hepatic Impairment on the Pharmacokinetics of Dalcetrapib
|
Phelan, Mary
|
|
2010
|
4 |
3 |
p. 215-216
2 p.
|
artikel
|
| 28 |
Effects of an Insoluble Fraction of Soy Protein Versus Milk Protein on Plasma Lipids and Fecal Bile Acids in Men and Women with Hypercholesterolemia
|
Maki, Kevin Carl
|
|
2010
|
4 |
3 |
p. 211-
1 p.
|
artikel
|
| 29 |
Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk
|
Constance, Christian
|
|
2010
|
4 |
3 |
p. 224-225
2 p.
|
artikel
|
| 30 |
Effects of Vitamin D Supplementation on 25-Hydroxyvitamin D and Markers of Cardiovascular Disease Risk in Subjects with High Waist Circumference
|
Maki, Kevin Carl
|
|
2010
|
4 |
3 |
p. 208-209
2 p.
|
artikel
|
| 31 |
Efficacy and Safety of Fixed-Dose Rosuvastatin/Fenofibric Acid Versus Simvastatin Monotherapy in Patients with Elevated Low-Density Lipoprotein Cholesterol and Triglycerides
|
Roth, Eli M.
|
|
2010
|
4 |
3 |
p. 213-
1 p.
|
artikel
|
| 32 |
Efficacy and Selectivity of a Direct Absorption of Lipoproteins Apheresis System in Familial Hypercholesterolemic Omani Patients
|
Alrasadi, Khalid Humaid
|
|
2010
|
4 |
3 |
p. 199-
1 p.
|
artikel
|
| 33 |
Efficacy of Switching from Statin Monotherapy to Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients Analyzed by Baseline LDL-C
|
Brudi, Philippe
|
|
2010
|
4 |
3 |
p. 204-205
2 p.
|
artikel
|
| 34 |
Extended-Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia
|
Bostom, Andrew G.
|
|
2010
|
4 |
3 |
p. 198-199
2 p.
|
artikel
|
| 35 |
Extended-Release Nicotinic Acid Versus Inositol Hexanicotinate for the Treatment of Dyslipidemia
|
Keenan, Joseph
|
|
2010
|
4 |
3 |
p. 216-217
2 p.
|
artikel
|
| 36 |
Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High Risk Hypercholesterolemic Patients Stratified by Previous Statin Treatment Potency
|
Farnier, Michael
|
|
2010
|
4 |
3 |
p. 207-208
2 p.
|
artikel
|
| 37 |
Fibrates Lower the Risk of Myocardial Infarction but Not Stroke or Mortality in Patients with Cardiovascular Disease: A Meta-Analysis and Systematic Review∗
|
Al Badarin, Firas
|
|
2010
|
4 |
3 |
p. 222-223
2 p.
|
artikel
|
| 38 |
From the Editor-in-Chief
|
Brown, W. Virgil
|
|
2010
|
4 |
3 |
p. 139-141
3 p.
|
artikel
|
| 39 |
Hepatic Lipase Deficiency in a Middle-Eastern/Arabic Male∗
|
Al-Riyami, Nafila Bazdawi
|
|
2010
|
4 |
3 |
p. 226-227
2 p.
|
artikel
|
| 40 |
High Low-Density Lipoprotein Associated with a Higher Early Viral Response (EVR) Rates in Genotype 1 Chronic Hepatitis C (CHC)∗
|
Nachnani, Jagdish S.
|
|
2010
|
4 |
3 |
p. 227-228
2 p.
|
artikel
|
| 41 |
Improvements in Lipid Ratios with the Combination of Rosuvastatin 5 mg and Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia
|
Rosenson, Robert S.
|
|
2010
|
4 |
3 |
p. 206-
1 p.
|
artikel
|
| 42 |
Inverse Relationship Between High-Density Lipoprotein Cholesterol Raising and High-Sensitivity C-Reactive Protein Reduction in Older Patients Treated with Lipid-Lowering Therapy
|
Brown, W. Virgil
|
|
2010
|
4 |
3 |
p. 223-
1 p.
|
artikel
|
| 43 |
Letter to the Editor
|
Trenkle, Douglas
|
|
2010
|
4 |
3 |
p. 196-
1 p.
|
artikel
|
| 44 |
Long-Term Efficacy of Rosuvastatin and Fenofibric Acid 20 mg/135 mg in Dyslipidemic Patients Initially Treated with Rosuvastatin and Fenofibric Acid 10 mg/135 mg
|
Ferdinand, Keith C.
|
|
2010
|
4 |
3 |
p. 210-211
2 p.
|
artikel
|
| 45 |
Long-Term Outcomes from the Utilization of a Novel Web-Based Lipid Management Software in a Single Specialty Cardiology Practice
|
Baykal, Demir
|
|
2010
|
4 |
3 |
p. 225-226
2 p.
|
artikel
|
| 46 |
Long-Term Outcomes in Patients with Severe Hypertriglyceridemia—Simulation Using the Archimedes Model
|
Arondekar, Bhakti
|
|
2010
|
4 |
3 |
p. 229-230
2 p.
|
artikel
|
| 47 |
Low-Density Lipoprotein (LDL) Particle Number is Heterogeneous among Persons with and Without Type 2 Diabetes and LDL Cholesterol <100 mg/dL
|
Pourfarzib, Ray
|
|
2010
|
4 |
3 |
p. 229-
1 p.
|
artikel
|
| 48 |
Mipomersen, a First-in-Class Apolipoprotein B Synthesis Inhibitor, Lowers Lipoprotein (a) in Patients with Homozygous Familial Hypercholesterolemia
|
Cromwell, William C.
|
|
2010
|
4 |
3 |
p. 221-
1 p.
|
artikel
|
| 49 |
New mutations in APOB100 involved in familial hypobetalipoproteinemia
|
Brusgaard, Klaus
|
|
2010
|
4 |
3 |
p. 181-184
4 p.
|
artikel
|
| 50 |
News from the NLA
|
|
|
2010
|
4 |
3 |
p. 142-143
2 p.
|
artikel
|
| 51 |
No Clinically Relevant Drug-Drug Interactions Between Dalcetrapib and a Monophasic Oral Contraceptive (Microgynon-30®)
|
Young, Anne-Marie
|
|
2010
|
4 |
3 |
p. 216-
1 p.
|
artikel
|
| 52 |
Omega-3 Fatty Acid Nutritional Labeling Content of Dietary Fish Oil Supplements: A Systematic Review∗
|
Zargar, Atanaz
|
|
2010
|
4 |
3 |
p. 209-210
2 p.
|
artikel
|
| 53 |
Predicting the Risk of Atherothrombotic Disease with Lipid Ratios
|
Feeman Jr., William E.
|
|
2010
|
4 |
3 |
p. 199-200
2 p.
|
artikel
|
| 54 |
Predictors of Anterior and Posterior Wall Carotid Intima Media Thickness Progression in Men and Women at Moderate Risk of Coronary Heart Disease
|
Maki, Kevin Carl
|
|
2010
|
4 |
3 |
p. 209-
1 p.
|
artikel
|
| 55 |
Predictors of Combination Therapy for the Treatment of Dyslipidemia in the Actual Clinical Practice-Setting
|
Nair, Radhika
|
|
2010
|
4 |
3 |
p. 218-
1 p.
|
artikel
|
| 56 |
Prevalence and Pattern of Dyslipidemia in Omani Patients Undergoing Coronary Artery Bypass Surgery
|
Al-Sabti, Hilal
|
|
2010
|
4 |
3 |
p. 201-202
2 p.
|
artikel
|
| 57 |
Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age
|
Aboul Ella, Nebal A.
|
|
2010
|
4 |
3 |
p. 185-195
11 p.
|
artikel
|
| 58 |
Prognostic Factors that Influence the Risk of Intensification of Anti-Hyperglycemic Medication Among Patients with Type 2 Diabetes
|
Maccubbin, Darbie
|
|
2010
|
4 |
3 |
p. 216-
1 p.
|
artikel
|
| 59 |
Prognostic Utility of Lipid Parameters in Prediction of New-Onset Microalbuminuria in Hypertensive Patients∗
|
Manickam, Palaniappan
|
|
2010
|
4 |
3 |
p. 217-
1 p.
|
artikel
|
| 60 |
Relationships Between Low-Density Lipoprotein Cholesterol, Apolipoprotein B, and Non-High-Density Lipoprotein Cholesterol with High-Sensitivity C-Reactive Protein in Hypercholesterolemic Patients at Risk for Cardiovascular Disease
|
O Keefe, James H.
|
|
2010
|
4 |
3 |
p. 224-
1 p.
|
artikel
|
| 61 |
Reply
|
Nash, David T.
|
|
2010
|
4 |
3 |
p. 196-197
2 p.
|
artikel
|
| 62 |
Response by Sex to Statin and Ezetimibe Versus Statin Monotherapy: Pooled Analysis from 22,913 Hyperlipidemic Patients
|
Robinson, Jennifer
|
|
2010
|
4 |
3 |
p. 200-
1 p.
|
artikel
|
| 63 |
Rise in Plasma Triglycerides: An Early Marker of Oxidative Stress in Urban Indians
|
Dudani, Sharmila
|
|
2010
|
4 |
3 |
p. 202-203
2 p.
|
artikel
|
| 64 |
Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin in Patients 65 Years of Age and Older
|
Zieve, Franklin Joseph
|
|
2010
|
4 |
3 |
p. 225-
1 p.
|
artikel
|
| 65 |
Sex and Ethnic Disparities in High-Density Lipoprotein Subclasses∗
|
Manickam, Palaniappan
|
|
2010
|
4 |
3 |
p. 214-215
2 p.
|
artikel
|
| 66 |
Should we use apoB for risk assessment and as a target for treatment? †
|
Brown, W. Virgil
|
|
2010
|
4 |
3 |
p. 144-151
8 p.
|
artikel
|
| 67 |
Simple Changes in Diet and Exercise: A Longitudinal, Retrospective Analysis
|
Uusinarkaus, Kari
|
|
2010
|
4 |
3 |
p. 227-
1 p.
|
artikel
|
| 68 |
Simultaneous Achievement of Optimal Lipid Targets with the Combination of Rosuvastatin 5 mg + Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia
|
Rosenson, Robert S.
|
|
2010
|
4 |
3 |
p. 206-207
2 p.
|
artikel
|
| 69 |
Stability of Lipid Responses to Prescription Omega-3 Acid Ethyl Esters Plus Simvastatin Over Two Years
|
Maki, Kevin Carl
|
|
2010
|
4 |
3 |
p. 207-
1 p.
|
artikel
|
| 70 |
Switching from Any Statin Brand to Ezetimibe/Simvastatin 10/20 mg is More Effective at Lowering Plasma Lipids Compared with Rosuvastatin 10 mg
|
Brudi, Philippe
|
|
2010
|
4 |
3 |
p. 201-
1 p.
|
artikel
|
| 71 |
Switching from Statin Monotherapy to EZE/Simva or Rosuva Modifies Apo B, LDL-C, and non-HDL-C Correlations in Patients at High Risk of Coronary Disease
|
Brudi, Philippe
|
|
2010
|
4 |
3 |
p. 205-
1 p.
|
artikel
|
| 72 |
Table of Contents
|
|
|
2010
|
4 |
3 |
p. vii-viii
nvt p.
|
artikel
|
| 73 |
The Ability of Therapy with Ezetimibe/Simvastatin or Ezetimibe/Simvastatin/Fenofibrate to Achieve Lipid Targets in Mixed Dyslipidemic Patients
|
Farnier, Michael
|
|
2010
|
4 |
3 |
p. 205-206
2 p.
|
artikel
|
| 74 |
The Lipid-Altering Effects of Extended-Release Niacin/Laropiprant Among Different Patient Subgroups
|
Bays, Harold Edward
|
|
2010
|
4 |
3 |
p. 215-
1 p.
|
artikel
|
| 75 |
The Role of Innate Inflammatory Mediators in Acute Myocardial Infarction∗
|
Poterucha, Joseph Thomas
|
|
2010
|
4 |
3 |
p. 203-204
2 p.
|
artikel
|
| 76 |
The Treatment of Dyslipidemia in Actual Practice Settings That Use Similar Inclusion Criteria to the ACCORD Lipid Trial
|
Nair, Radhika
|
|
2010
|
4 |
3 |
p. 218-219
2 p.
|
artikel
|
| 77 |
Why is non−high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
|
Sniderman, Allan
|
|
2010
|
4 |
3 |
p. 152-155
4 p.
|
artikel
|
| 78 |
28-Year Experience with Plasma Exchange and Low-Density Lipoprotein Apheresis in Managing a Patient with Familial Hypercholesterolemia: A Case Report
|
Reddy, Ramakrishna L.
|
|
2010
|
4 |
3 |
p. 230-231
2 p.
|
artikel
|
Tijdschrift beschrijving